ITOS: Rega marang dodolan iTeos Therapeutics Inc
iTeos Therapeutics (ITOS) operates in the advanced immuno-oncology segment with high growth potential. The price/sales multiple on this GURU.Markets chart helps track the gap between quotes and revenues, where the value of 11.00 represents the current figure. Market capitalization relies on payments from GSK for the joint development of antibodies, while revenues are based on research milestone bonuses and future royalties.
Rincian metrik lan analitis perusahaan iTeos (ITOS)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal iTeos Therapeutics|ITOS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal iTeos Pharma|ITOS - Utang perusahaan|Utang-utang marang aset resik iTeos|ITOS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan iTeos Therapeutics|Rasio likuiditas perantara iteostherapeutics.com
- data bathi resik lan rasio valuasi:
ITOS - Bathi resik|Penghasilan resik sing dikarepake iTeos Therapeutics|ITOS - Pangali P/E|Rasio prakiraan rega marang bathi iTeos Therapeutics Inc|ITOS - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan iTeos|ITOS - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) iTeos Therapeutics|ITOS - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan iteostherapeutics.com|ITOS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep iTeos Therapeutics
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis fundamental perusahaan:ITOS, iteostherapeutics.com
Analyzing the P/S volatility of iTeos Therapeutics (ITOS), an investor assesses the business's market value relative to its annual turnover, which determines the company's resilience to industry shocks. This ratio compares total capitalization with revenue, reflecting the extent to which the proprietary antibody immuno-oncology platform and the B2B development patent perimeter justify current market expectations compared to sector averages.
Karo sapa iTeos Therapeutics saingan
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Koefisien rega marang pendapatan Protagonist Corp PTGX|IMVT (Immunovant, Inc.) - Kapitalisasi marang pendapatan|KNSA: Kapitalisasi marang volume dodolan|GRFS (Grifols) - Multiplikator P/S|Rega marang dodolan Adaptive Biotech ADPT|Rasio rega marang pendapatan Celldex (CLDX)|AUPH - Rega marang dodolan|Rasio rega marang pendapatan BioCryst BCRX|Koefisien rega marang pendapatan veratx.com (VERA)|DNTH: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PHVS (Pharvaris NV)|ABCL (AbCellera Biologics Inc) - Kapitalisasi marang pendapatan|TRML: Kapitalisasi marang volume dodolan|PGEN (Precigen, Inc.) - Multiplikator P/S|PHAR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NKTR|UPB - Rega marang dodolan|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Rasio kapitalisasi pasar marang pendapatan IMNM|Gossamer Bio, Inc. - Multiplikator P/S|KALV - Multiplikator P/S|Septerna (SEPN) - Rasio rega marang pendapatan|Rasio rega marang dodolan PVLA (Pieris Pharma)|SVRA (Savara Corp) - Multiplikator P/S|Rega marang dodolan Rigel Corp RIGL|Kapitalisasi marang pendapatan ANAB (AnaptysBio, Inc.)|Multiplikator P/S astriatx.com (ATXS)|enGene - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan RAPT (RAPT Therapeutics Inc.)|Aerovate - Multiplikator P/S|Koefisien rega marang pendapatan Aclaris Therapeutics, Inc ACRS|KYTX: Multiplikator P/S|Kapitalisasi marang pendapatan tizianalifesciences.com|Rasio rega marang pendapatan Cabaletta Bio|Ventyx Biosciences Inc. (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|Koefisien rega marang pendapatan Avalo Therapeutics Inc|Eledon Pharmaceuticals - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan AGEN (agenusbio.com)|CLYM - Rasio rega marang pendapatan|Rega marang dodolan Zura Bio Ltd|aTyr (ATYR) - Rasio rega marang pendapatan|ADAG - Koefisien rega marang pendapatan|Rasio rega marang pendapatan ImageneBio|Shattuck Therapeutics - Rasio rega marang dodolan|Multiplikator P/S EQ|CNTB (connectbiopharm.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S IMUX (Immunic)|Multiplikator P/S Atara Biotherapeutics, Inc. ATRA|IFRX - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan XFOR (x4pharma.com)|adicetbio.com (ACET) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Celularity|INMB (INmune Bio Corp) - Multiplikator P/S|Multiplikator P/S Barinthus Biotherapeutics Corp|Kapitalisasi marang pendapatan KZR (Kezar Life Sciences)|SABS (sabbiotherapeutics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AKTX (Akari Therapeutics Plc)|Koefisien rega marang pendapatan Enlivex Therapeutics Ltd (ENLV)|QTTB - Rasio rega marang pendapatan|GeoVax Corp (GOVX) - Kapitalisasi marang pendapatan|Edesa Biotech, Inc. (EDSA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ibioinc.com|Kapitalisasi marang pendapatan CARM|Multiplikator P/S XTL Biopharmaceuticals Ltd|Rasio rega marang pendapatan Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Rega marang dodolan|Aditxt Corp - Multiplikator P/S|Koefisien rega marang pendapatan GRI Bio Inc GRI|XRTX (XORTX) - Kapitalisasi marang pendapatan|HIND: Kapitalisasi marang volume dodolan|REVB (Revelation Biosciences) - Multiplikator P/S|Rega marang dodolan indaptusrx.com INDP|Rasio rega marang pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Rega marang dodolan|Rasio rega marang pendapatan Affimed N.V. AFMD|Koefisien rega marang pendapatan Allakos Inc (ALLK)|HOOK: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IGMS (IGM Biosciences, Inc.)|OCEA (Ocean Biomedical) - Kapitalisasi marang pendapatan|TCBP: Kapitalisasi marang volume dodolan|THRD (Third Harmonic Bio, Inc) - Multiplikator P/S
